[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2018 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
28-May-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Mar-2018 [#1]
Profit Trend
QoQ- 1.5%
YoY- 25.11%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 498,722 510,784 514,500 533,036 467,987 474,312 480,710 2.47%
PBT 59,666 56,010 52,340 53,020 51,796 51,961 49,528 13.18%
Tax -12,025 -11,648 -10,368 -10,432 -9,696 -11,518 -11,118 5.35%
NP 47,641 44,362 41,972 42,588 42,100 40,442 38,410 15.39%
-
NP to SH 47,641 44,362 41,972 43,128 42,492 40,829 38,434 15.34%
-
Tax Rate 20.15% 20.80% 19.81% 19.68% 18.72% 22.17% 22.45% -
Total Cost 451,081 466,421 472,528 490,448 425,887 433,869 442,300 1.31%
-
Net Worth 483,173 501,487 209,983 206,429 479,809 474,230 463,071 2.86%
Dividend
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Div 36,403 13,197 8,399 - 23,711 - 13,947 89.23%
Div Payout % 76.41% 29.75% 20.01% - 55.80% - 36.29% -
Equity
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Net Worth 483,173 501,487 209,983 206,429 479,809 474,230 463,071 2.86%
NOSH 661,881 661,881 650,902 278,959 278,959 278,959 278,959 77.61%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 9.55% 8.69% 8.16% 7.99% 9.00% 8.53% 7.99% -
ROE 9.86% 8.85% 19.99% 20.89% 8.86% 8.61% 8.30% -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 75.35 77.41 183.76 191.08 167.76 170.03 172.32 -42.30%
EPS 7.26 6.79 6.44 15.28 15.09 14.49 13.76 -34.62%
DPS 5.50 2.00 3.00 0.00 8.50 0.00 5.00 6.54%
NAPS 0.73 0.76 0.75 0.74 1.72 1.70 1.66 -42.08%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
RPS 51.81 53.06 53.45 55.37 48.61 49.27 49.94 2.47%
EPS 4.95 4.61 4.36 4.48 4.41 4.24 3.99 15.41%
DPS 3.78 1.37 0.87 0.00 2.46 0.00 1.45 89.08%
NAPS 0.5019 0.5209 0.2181 0.2144 0.4984 0.4926 0.481 2.86%
Price Multiplier on Financial Quarter End Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 -
Price 0.95 1.23 1.30 2.80 2.53 2.20 2.25 -
P/RPS 1.26 1.59 0.71 1.47 1.51 1.29 1.31 -2.55%
P/EPS 13.20 18.30 8.67 18.11 16.61 15.03 16.33 -13.19%
EY 7.58 5.47 11.53 5.52 6.02 6.65 6.12 15.28%
DY 5.79 1.63 2.31 0.00 3.36 0.00 2.22 89.14%
P/NAPS 1.30 1.62 1.73 3.78 1.47 1.29 1.36 -2.95%
Price Multiplier on Announcement Date
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Date 18/02/19 28/11/18 26/11/18 28/05/18 28/02/18 17/11/17 25/08/17 -
Price 1.03 1.07 1.08 3.35 2.97 2.20 2.03 -
P/RPS 1.37 1.38 0.59 1.75 1.77 1.29 1.18 10.43%
P/EPS 14.31 15.92 7.20 21.67 19.50 15.03 14.73 -1.90%
EY 6.99 6.28 13.88 4.62 5.13 6.65 6.79 1.94%
DY 5.34 1.87 2.78 0.00 2.86 0.00 2.46 67.41%
P/NAPS 1.41 1.41 1.44 4.53 1.73 1.29 1.22 10.10%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment